Respiratory Restriction Leaded by Conventional or Minimally Invasive Sugical Repair of Oesophageal Atresia in Children (RestriMIS2)
Assessment of Respiratory Restriction Caused by Chest Wall Abnormalities Following Conventional or Minimal Invasive Surgical Repair of Type III Esophageal Atresia in School Age Children
Children born with esophageal atresia need surgery shortly after birth. For many years, the standard operation was a thoracotomy, an opening in the chest that can sometimes lead to changes in the shape of the chest wall. Although these changes are visible on X rays, doctors still do not fully understand how much they affect breathing later in childhood. A newer, less invasive technique called thoracoscopy uses small incisions and appears to cause fewer chest deformities, but its impact on lung function has not yet been clearly established.
This study aims to compare the breathing capacity of children aged 6 to 9 who were operated on using either thoracotomy or thoracoscopy. The main question is whether one group is more likely to develop restrictive lung syndrome, a condition in which the lungs cannot expand normally. To answer this, the study relies on lung function tests and chest X rays performed during routine follow up visits.
Beyond this primary goal, the study also examines other possible breathing problems, the presence of chest wall abnormalities, and factors that might influence lung health, such as nutrition, physical activity, associated malformations, and overall quality of life.
A total of at least 360 children across France will participate. They are identified through national registries and invited during scheduled follow up consultations.
연구 개요
상태
상태
정황
정황
연구 유형
연구 유형
등록 (추정된)
등록
연락처 및 위치
연구 연락처
연구 연락처
- 이름: Francoise SCHMITT, MD
- 전화번호: +33 2 41 35 42 90
- 이메일: FrSchmitt@chu-angers.fr
연구 연락처 백업
- 이름: Josue Rakotonjanahary
- 전화번호: +33 2 41 35 57 40
- 이메일: JoRakotonjanahary@chu-angers.fr
연구 장소
-
-
-
Amiens, 프랑스, 80054
- CHU Amiens, Département de Pédiatrie, centre d'activité "chirurgie pédiatrique viscérale"
-
연락하다:
- Philippe BUISSON, MD
- 전화번호: +33 3 22 08 75 60
- 이메일: buisson.philippe@chu-amiens.fr
-
수석 연구원:
- Philippe BUISSON, MD
-
Angers, 프랑스, 49933
- CHU Angers, Service Urgences, Médecine, Psychiatrie et Chirurgie Pédiatriques
-
연락하다:
- Francoise SCHMITT, MD
- 전화번호: 2 41 35 42 90
- 이메일: FrSchmitt@chu-angers.fr
-
연락하다:
-
수석 연구원:
- francoise SCHMITT, MD
-
Clermont-Ferrand, 프랑스, 63003
- CHU Clermont-Ferrand, Service de pédiatrie générale et multidisciplinaire
-
연락하다:
- Carole Egron, MD
- 전화번호: +33 4 73 75 00 24
- 이메일: cegron@chu-clermontferrand.fr
-
수석 연구원:
- Carole EGRON, MD
-
Dijon, 프랑스, 21000
- CHU Dijon, Service de chirurgie pédiatrique
-
연락하다:
- Michel FRANCOIS, MD
- 전화번호: +33 3 80 28 14 35
- 이메일: michel.françois@chu-dijon.fr
-
수석 연구원:
- Michel FRANCOIS, MD
-
Grenoble, 프랑스, 38700
- CHU Grenoble, Service de chirurgie pédiatrique
-
연락하다:
- Pierre-Yves RABATTU, MD
- 전화번호: +33 4 76 76 59 00
- 이메일: pyrabattu@chu-grenoble.fr
-
수석 연구원:
- Pierre-Yves RABATTU, MD
-
Le Kremlin-Bicêtre, 프랑스, 94275
- Hôpital Bicêtre, AP-HP, Chirurgie Viscérale Pédiatrique
-
연락하다:
- Khadidja KHADIR, MD
- 전화번호: +33 1 45 21 21 21
- 이메일: khadidja.khadir@aphp.fr
-
수석 연구원:
- Khadidja KHADIR, MD
-
Lyon, 프랑스, 69677
- Hospices Civils de Lyon, Service d'Hepato-Gastroentérologie et Nutrition Pédiatrique
-
연락하다:
- Nicolas CARON, MD
- 전화번호: +33 4 72 35 70 50
- 이메일: nicolas.caron@chu-lyon.fr
-
수석 연구원:
- Nicolas CARON, MD
-
Nantes, 프랑스, 44093
- CHU Nantes, Hôpital Mère-Enfant, Service de Chirurgie Infantile
-
연락하다:
- Audrey GUINOT, MD
- 전화번호: +33 2 40 08 35 85
- 이메일: audrey.guinot@chu-nantes.fr
-
수석 연구원:
- Audrey GUINOT, MD
-
Paris, 프랑스, 75015
- Hôpital Necker Enfants Malades, AP-HP, Service de Pneumologie et Allergologie Pédiatriques
-
연락하다:
- Rola ABOU TAAM, MD
- 전화번호: +33 1 44 38 15 65
- 이메일: rola.aboutaam@aphp.fr
-
수석 연구원:
- Rola ABOU TAAM, MD
-
Strasbourg, 프랑스, 67098
- CHU Strasbourg, Service de chirurgie pédiatrique
-
연락하다:
- Isabelle TALON, MD
- 전화번호: +33 3 88 12 73 17
- 이메일: isabelle.talon@chru-strasbourg.fr
-
Toulouse, 프랑스, 31059
- CHU Toulouse, Service de Chirurgie Viscérale Pédiatrique
-
연락하다:
- Aurélie LE MANDAT, MD
- 전화번호: +33 5 34 55 85 44
- 이메일: lemandat.a@chu-toulouse.fr
-
수석 연구원:
- Aurelie LE MANDAT, MD
-
-
참여기준
자격 기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
Eligible patients in both groups are mainly identified through the national esophageal atresia registry (RENATO, CRACMO, CHU Lille).
설명
For thoracoscopy group:
Inclusion Criteria:
- Child operated on by thoracoscopy for type 3 AO (excluding long gap) according to Ladd's classification
- Child aged 6 to 10 years old
- Consent from parents (or legal guardians) and the child's agreement to participate in the study
Exclusion Criteria:
- Heart or lung malformation diagnosed at birth and requiring surgery
- Conversion from thoracoscopy to thoracotomy during the procedure
- Child who has had more than one thoracic surgery (reoperation for AO, other reasons for thoracic surgery including heart surgery)
- For Thoracotomy group*:
Inclusion Criteria :
--Child operated on by thoracotomy for type 3 AO (excluding long gap) according to the Ladd classification
- Child aged 6 to 10 years old
- Consent from parents (or legal guardians) and the child's agreement to participate in the study
Exclusion Criteria:
- Heart or lung malformation diagnosed at birth and requiring surgery
- Child who has had more than one thoracic surgery (reoperation for AO, other reason for thoracic surgery including heart surgery)
- Child operated on for type 3 AO via thoracotomy (excluding long gap) according to Ladd's classification
For each patient who underwent thoracoscopic surgery included in the study, two patients who had thoracotomy, matched according to known or suspected confounding factors for restrictive syndromes from the RestriMIS1 (NCT04136795) study**, will be included.
*It's possible that some children had multiple consecutive surgeries. In those cases, if one of the procedures was a thoracotomy, the children will be classified in the thoracotomy group (the more major surgery).
**Prematurity, birth weight, presence of tracheomalacia, and GERD during the neonatal period (clinically and/or on additional tests)
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 관찰 모델: COHORT
- 시간 관점: PROSPECTIVE
그룹/코호트 수
코호트 및 개입
그룹/코호트그룹/코호트 |
|---|
|
thoracoscopy group
minimally invasive surgical approach |
|
thoracotomy arm
conventionnal surgical approach |
연구는 무엇을 측정합니까?
주요 결과 측정
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
to assess the presence of a restrictive lung syndrome in patients with type 3 esophageal atresia (EA) depending on the type of surgical approach used (conventional or minimally invasive).
기간: Lung function tests can be done up to 2 years after the multidisciplinary consultation (Visit 0)
|
Rate of restrictive syndrome according to the type of surgical approach (conventional or minimally invasive), defined by spirometry data: FEV1/FVC > -1.64 Z-score and FVC < -1.64 Z-score, according to the ATS/ERS-GLI (American Thoracic Society & European Respiratory Society - Global Lung Initiative) recommendations published in 2012 (Quanjer) and reviewed en 2022. |
Lung function tests can be done up to 2 years after the multidisciplinary consultation (Visit 0)
|
2차 결과 측정
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
to evaluate the importance of restrictive syndrome
기간: importance of restrictive syndrome can be evaluated up to 2 years after the multidisciplinary consultation (visit 0)
|
The importance of restrictive syndrome is classified into 3 levels: mild restrictive syndrome [-1.64 > z-score ≥ -2.5], moderate [-2.5 > z-score ≥ -4.0], or severe [-4.0 > z-score]). |
importance of restrictive syndrome can be evaluated up to 2 years after the multidisciplinary consultation (visit 0)
|
|
Looking for other respiratory parameters
기간: the link between chest skeletal abnormalities found on chest X-rays and lung impact can be evaluated up to 2 years after the multidisciplinary consultation
|
Other respiratory changes are examined by measuring other respiratory parameters (forced vital capacity, FEF 25-75, Tiffeneau ratio, reversibility), which help highlight obstructive or mixed syndromes (FEV1/FVC < -1.64 and FVC < -1.64 z-score) when present |
the link between chest skeletal abnormalities found on chest X-rays and lung impact can be evaluated up to 2 years after the multidisciplinary consultation
|
|
to assess the link between chest skeletal abnormalities found on chest X-rays and lung impact
기간: until spirometry is completed, within a maximum period of 2 years
|
The following factors are considered when estimating the risk of association with or without a restrictive syndrome (history data like prematurity or types of malformations associated with AO III, surgical and medical care data in the neonatal period and childhood, growth data at one year and at 6-10 years), lung care, physical activity, the PedsQL score (for children aged 6 to 10), and responses to the EA-QoL questionnaire (for children aged 8 to 10). |
until spirometry is completed, within a maximum period of 2 years
|
|
rate of postoperative complications and any necessary reoperations
기간: up to 2 years after the multidisciplinary consultation
|
The rate of postoperative complications is assessed by type of surgery as well as any necessary follow-up surgeries. |
up to 2 years after the multidisciplinary consultation
|
|
Respiratory-related quality of life during childhood
기간: up to 2 years after the multidisciplinary consultation
|
It will be estimated through both need for lung care, physical activity, PedsQL score (for children aged 6 to 10), and EA-QoL questionnaire (for children aged 8 to 10). |
up to 2 years after the multidisciplinary consultation
|
|
to assess the existence of a cause-and-effect link between the restrictive syndrome and the surgical technique used
기간: through study completion, within a maximum of 24 months
|
The acceptability of the existence of a causal link is assessed using sensitivity analysis, which estimates how robust the results are while taking into account missing data and different clinical scenarios (including a per-protocol analysis in addition to the intention-to-treat analysis). |
through study completion, within a maximum of 24 months
|
|
to assess the mortality rate
기간: through study completion, an average 7 years
|
The death rate for each surgery group will be described based on the follow-up in the study, that is, the date of the surgery (combined data for all patients in the registry). |
through study completion, an average 7 years
|
|
Looking for lung volumes variations
기간: the link between chest skeletal abnormalities found on chest X-rays and MRI lung volumes can be evaluated up to 2 years after the multidisciplinary consultation
|
Lung volume variations will be measured by dynamic respiratory MRI data |
the link between chest skeletal abnormalities found on chest X-rays and MRI lung volumes can be evaluated up to 2 years after the multidisciplinary consultation
|
공동 작업자 및 조사자
연구 기록 날짜
연구 주요 날짜
연구 시작 (추정된)
연구 시작
기본 완료 (추정된)
기본 완료
연구 완료 (추정된)
연구 완료
연구 등록 날짜
최초 제출
최초 제출
QC 기준을 충족하는 최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
처음 게시됨
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
마지막 업데이트 게시됨
QC 기준을 충족하는 마지막 업데이트 제출
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
키워드
기타 연구 ID 번호
기타 연구 ID 번호
- 49RC25_0432
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .